The Specific Regulation Of Immune Responses By CD8+ T Cells Restricted By The MHC Class Ib Molecule, Qa-1

Author:

Jiang Hong1,Chess Leonard1

Affiliation:

1. Department of Medicine and Pathology, Columbia University College of Physicians and Surgeons, New York, NY, 10032

Abstract

Over the last three decades considerable evidence has accumulated that CD8+ T cells regulate peripheral immune responses, in part, by specifically controlling the outgrowth of antigen-triggered CD4+ T cells. This regulatory function of CD8+ T cells has been shown, in vivo, to control the emergence of autoreactive CD4+ T cells as well as CD4+ T cells reactive to conventional antigens, including alloantigens. In this review, we summarize the evidence that this immune suppression mediated by CD8+ T cells is dependent, in part, on specific cognate interactions between MHC class I–restricted regulatory CD8+ cells and antigen-activated CD4+ T cells. Moreover, we review the evidence that regulatory CD8+ T cells recognize antigen-activated CD4+ T cells in a TCR specific manner restricted by the MHC class Ib molecule, Qa-1. The Qa-1 molecule may be uniquely qualified to serve this MHC restrictive function because, unlike conventional MHC molecules, it is preferentially and transiently expressed on activated and not resting CD4+ T cells. This may assure that only recently antigen-activated CD4+ T cells expressing Qa-1/TCR peptide complexes will induce regulatory CD8+ T cells and subsequently become susceptible to regulation. Because Qa-1 also binds to self Qdm peptides that trigger NK (CD94/ NKG2) receptors on CD8+ T cells, the machinery for homeostatic regulation of regulatory CD8+ T cells can be envisioned. Finally, we propose a model by which these TCR specific, Qa-1-restricted regulatory CD8+ T cells selectively downregulate antigen-activated T cells expressing TCRs of certain affinities. Ultimately these regulatory CD8+ T cells control the peripheral TCR repertoire during the course of immune responses to both self and foreign antigens.

Publisher

Annual Reviews

Subject

Immunology,Immunology and Allergy

Cited by 146 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3